BOUL.ST - Boule Diagnostics AB (publ)

Stockholm - Stockholm Real Time Price. Currency in SEK

Boule Diagnostics AB (publ)

Domnarvsgatan 4
Spanga 163 53
Sweden
46 87 44 77 00
http://www.boule.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Fredrik DalborgCEO & Group Pres3.67MN/A1972
Ms. Christina RubenhagSr. VP & CFON/AN/AN/A
Ms. Eva EkermannHR DirectorN/AN/AN/A
Ms. Karen BornsteinHead of Marketing, North & South AmericaN/AN/AN/A
Mr. Michael EliottHead of Devel. - Reagents & ConsumablesN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. It provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning kits and plastic micro capillaries under the Swelab, Medonic, and Quintus brands; and veterinary clinical chemistry analyzer and diagnostics systems under the Exigo brand. The company sells its products directly in Sweden and the United States, as well as through distributors internationally. It serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and companies in blood diagnostics. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.

Corporate Governance

Boule Diagnostics AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.